Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Myelin Basic Protein-Induced Production of Tumor Necrosis Factor-α and Interleukin-6, and Presentation of the Immunodominant Peptide MBP85-99 by B Cells from Patients with Relapsing-Remitting Multiple Sclerosis.
A qualitative investigation of exercising with MS and the impact on the spousal relationship.
Myelin repair by transplantation of myelin-forming cells in globoid cell leukodystrophy.
Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral Encephalitis.
Characteristics of Patients With Relapsing Remitting Multiple Sclerosis Taking Once Daily Fingolimod Capsules In The United States.
Multiple sclerosis in families: risk factors beyond known genetic polymorphisms.
Response to 'Re. Doppler Ultrasound Examination of Multiple Sclerosis Patients and Control Participants: Inter-observer Agreement and Association with Disease'
Inhibition of β-oxidation is not a valid therapeutic tool for reducing oxidative stress in conditions of neurodegeneration.
A clinical update on the significance of the gut microbiota in systemic autoimmunity.
Effect of Multiple Sclerosis Disease-Modifying Therapies on B Cells and Humoral Immunity.
Diffusion abnormality in Balo's concentric sclerosis: clues for the pathogenesis.
Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis.
Cytosolic phospholipase A2 plays a crucial role in ROS/NO signaling during microglial activation through the lipoxygenase pathway.
N'-(arylsulfonyl)pyrazoline-1-carboxamidines as novel, neutral 5-hydroxytryptamine 6 receptor (5-HT₆R) antagonists with unique structural features.
Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease.
Tracking successive Wallerian degenerations in a relapsing-remitting multiple sclerosis patient.
Phenotyping primary human microglia: tight regulation of LPS responsiveness.
Inflammation-independent defective early B cell tolerance checkpoints in rheumatoid arthritis.
Gilenya® data confirm reducing brain shrinkage matters for people with MS due to its association with long-term disability progression
[A young woman with central facial nerve palsy].
Celastrol and Its Role in Controlling Chronic Diseases.
Corpus callosum thickness in children: an MR pattern-recognition approach on the midsagittal image.
Genetics of rat neuroinflammation.
Cutaneous Adverse Events in the Randomized, Double-Blind, Active-Comparator DECIDE Study of Daclizumab High-Yield Process Versus Intramuscular Interferon Beta-1a in Relapsing-Remitting Multiple Sclerosis.
Health Care Resource Utilization Associated with Pediatric Patients Diagnosed with Relapsing Remitting Multiple Sclerosis.

Pages